These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35869502)

  • 1. Chorioretinal abnormalities in idiopathic intracranial hypertension: case reports.
    Ariello LE; Mello LGM; Pimentel SLG; Monteiro MLR
    Int J Retina Vitreous; 2022 Jul; 8(1):48. PubMed ID: 35869502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinal Manifestations of Idiopathic Intracranial Hypertension.
    Nichani P; Micieli JA
    Ophthalmol Retina; 2021 May; 5(5):429-437. PubMed ID: 32860958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unilateral papilledema and peripapillary polypoidal choroidal vasculopathy as the presenting manifestations of intracranial hypertension.
    Matos AMF; Cunha LP; Suzuki ACF; Mello LGM; Preti RC; Zacharias LC; Monteiro MLR
    Arq Bras Oftalmol; 2021; 84(6):598-601. PubMed ID: 34431881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and Progression of Chorioretinal Folds During Long-Duration Spaceflight.
    Ferguson CR; Pardon LP; Laurie SS; Young MH; Gibson CR; Brunstetter TJ; Tarver WJ; Mason SS; Sibony PA; Macias BR
    JAMA Ophthalmol; 2023 Feb; 141(2):168-175. PubMed ID: 36602790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidental idiopathic intracranial hypertension.
    Sargues LR; Sanchis MIS; Adsuara CM; Villanueva CG; Salvador BL; Taulet EC
    Rom J Ophthalmol; 2021; 65(2):187-190. PubMed ID: 34179586
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of the regression of papilledema with regional axon loss in idiopathic intracranial hypertension patients.
    Kabatas N; Eren Y; Nalcacioglu P; Caliskan S; Bicer T; Comoglu SS; Gurdal C
    Int Ophthalmol; 2021 Apr; 41(4):1467-1477. PubMed ID: 33481155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression of Bilateral Peripapillary Choroidal Neovascularization Associated with Idiopathic Intracranial Hypertension after Systemic Acetazolamide Treatment.
    Trivizki O; Wang L; Iyer P; Shi Y; Rosenfeld PJ; Rabinovitch D; Townsend J
    Case Rep Ophthalmol; 2022; 13(1):270-275. PubMed ID: 35702516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripapillary microperimetry for the diagnosis and follow-up of papilledema in cases treated for idiopathic intracranial hypertension.
    Elnahry GA; Elemary AM; Badr Eldin N; Nossair AA; Barrada OA; Elnahry AG
    Neurol Res; 2021 Jan; 43(1):61-70. PubMed ID: 32915708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Peripapillary Choroidal Neovascular Membrane in Patients With Idiopathic Intracranial Hypertension.
    Ozgonul C; Moinuddin O; Munie M; Lee MS; Bhatti MT; Landau K; Van Stavern GP; Mackay DD; Lebas M; DeLott LB; Cornblath WT; Besirli CG
    J Neuroophthalmol; 2019 Dec; 39(4):451-457. PubMed ID: 30951011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OCT measurements of optic nerve head changes in idiopathic intracranial hypertension.
    Huang-Link YM; Al-Hawasi A; Oberwahrenbrock T; Jin YP
    Clin Neurol Neurosurg; 2015 Mar; 130():122-7. PubMed ID: 25614195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of Choroid Thickness Using Optical Coherence Tomography to Monitor Intracranial Pressure in an Idiopathic Cranial Hypertension Model.
    Ozdemir I; Çevik S
    Neurol India; 2020; 68(3):636-639. PubMed ID: 32643677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part II: correlations and relationship to clinical features.
    ; Auinger P; Durbin M; Feldon S; Garvin M; Kardon R; Keltner J; Kupersmith MJ; Sibony P; Plumb K; Wang JK; Werner JS
    Invest Ophthalmol Vis Sci; 2014 Nov; 55(12):8173-9. PubMed ID: 25370513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaulating peripapillary vessel density ın regressed papilledema ın ıdiopathic ıntracranial hypertension patients.
    Kaya FS; Sonbahar O; Açar PA; Özbaş M; Yigit FU
    Photodiagnosis Photodyn Ther; 2021 Dec; 36():102551. PubMed ID: 34571274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal bevacizumab in the treatment of peripapillary choroidal neovascular membrane secondary to idiopathic intracranial hypertension.
    Lee IJ; Maccheron LJ; Kwan AS
    J Neuroophthalmol; 2013 Jun; 33(2):155-7. PubMed ID: 23235432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optical coherence tomography represents a sensitive and reliable tool for routine monitoring of idiopathic intracranial hypertension with and without papilledema.
    Huang-Link Y; Eleftheriou A; Yang G; Johansson JM; Apostolou A; Link H; Jin YP
    Eur J Neurol; 2019 May; 26(5):808-e57. PubMed ID: 30586220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-Layered Optic Disc Hemorrhages in Idiopathic Intracranial Hypertension.
    Sverdlichenko I; Micieli JA
    Case Rep Ophthalmol; 2021; 12(2):616-621. PubMed ID: 34326762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of optic nerve head changes with optic coherence tomography in patients with idiopathic intracranial hypertension.
    Eren Y; Kabatas N; Guven H; Comoglu S; Gurdal C
    Acta Neurol Belg; 2019 Sep; 119(3):351-357. PubMed ID: 30120685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation Between Optic Disc Peripapillary Capillary Network and Papilledema Grading in Patients With Idiopathic Intracranial Hypertension: A Study of Optical Coherence Tomography Angiography.
    Rodriguez Torres Y; Lee P; Mihlstin M; Tomsak RL
    J Neuroophthalmol; 2021 Mar; 41(1):48-53. PubMed ID: 31972713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optic Nerve Head Volumetry by Optical Coherence Tomography in Papilledema Related to Idiopathic Intracranial Hypertension.
    Dreesbach M; Joachimsen L; Küchlin S; Reich M; Gross NJ; Brandt AU; Schuchardt F; Harloff A; Böhringer D; Lagrèze WA
    Transl Vis Sci Technol; 2020 Feb; 9(3):24. PubMed ID: 32742754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Causes and Prognosis of Visual Acuity Loss at the Time of Initial Presentation in Idiopathic Intracranial Hypertension.
    Chen JJ; Thurtell MJ; Longmuir RA; Garvin MK; Wang JK; Wall M; Kardon RH
    Invest Ophthalmol Vis Sci; 2015 Jun; 56(6):3850-9. PubMed ID: 26070058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.